A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors

Human Gene Therapy

Volumn 8, Issue 5, 1997, Pages 533-544

  Pyles, Richard B ^a   Warnick, Ronald E ^b   Chalk, Claudia L ^b   Szanti, Bridget E ^a   Parysek, Linda M ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; URACIL DNA GLYCOSYLTRANSFERASE;

ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; MOUSE; NERVE CELL CULTURE; NONHUMAN; SCID MOUSE; TUMOR CELL LINE; TUMOR REGRESSION; TUMOR XENOGRAFT; VIRUS ATTENUATION; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

EID: 0030958391     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.5-533     Document Type: Article

References (28)

1. BOVIATSIS, E.J., CHASE, M., WEI, M.X., TAMIYA, T., HURFORD, R.K., KOWALL, N.W., TEPPER, R.I., BREAKFIELD, X.O., and CHIOCCA, E.A. (1994a). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus and retrovirus vectors. Hum. Gene Ther. 5, 183-191.
2. BOVIATSIS, E.J., PARK, J.S., SENA-ESTEVES, M., KRAMM, C.M., CHASE, M., EFIRD, J.T., WEI, M.X., BREAKEFIELD, X.O., and CHIOCCA, E.A. (1994b). Long-term survival of rats harbouring neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res. 54, 5745-5751.
3. 134.5, a gene nonessential for growth in culture. Science 250, 1262-1266.
4. DIX, R.D., MCKENDALL, R.R., and BARRINGER, J.R. (1983). Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect. Immun. 40, 103-112.
5. ERLICH, K.S., MILLS, J., CHATIS, P.A., MILLER, L., SCHAGER, E., and CRUMPACKER, C. (1989). Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 320, 293-296.
6. FOLEY, J., COHN, S.L., SALWEN, H.R., CHAGNOVICH, D., COWAN, J., MASON, K.L., and PARYSEK, L.M. (1991). Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res. 51, 6338-6345.
7. HARLOW, E., and LANE, D. (1988). Antibodies: A Laboratory Manual. (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) p. 418.
8. HEFFELFINGER, S.C., HAWKINS, H.H., BARRISH, J., TAYLOR, L., and DARLINGTON, G.J. (1992). SK Hep-1: A human cell line of endothelial origin. In Vitro Cell. & Dev. Biol. 28, 136-142.
9. KAPPLIT, M.G., TJUVAJEV, J.G., LEIB, D.A., BERK, J., PETTIGREW, K.D., POSNER, J.B., PFAFF, D.W., RABKIN, S.D., and BLASBERG, R.G. (1994). Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats. J. Neuro-Oncol. 19, 137-147.
10. ras, inhibition of cell proliferation and morphological changes. Oncogene 11, 325-335.
11. MCGEOCH, D.J., DALRYMPLE, M.A., DAVISON, A.J., DOLAN, A., FRAME, M.C., MCNAB, D., PERRY, L.J., SCOTT, J.E., and TAYLOR, P. (1988). The complete sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69, 1531-1574.
12. MARKERT, J.M., COEN, D.M., MALICK, A., MINETA, T., and MARTUZA, R.L. (1992). Expanded spectrum of viral therapy in the treatment of nervous system tumors. J. Neurosurg. 77, 590-594.
13. MARKERT, J.M., MALICK, A., COEN, D.M., and MARTUZA, R.L. (1993). Reduction of encephalitis in an experimental glioma therapy model with attenuated herpes simplex mutants that retain susceptibility to acyclovir. Neurosurgery 32, 597-602.
14. MARTUZA, R.L. (1992). Molecular neurosurgery for glial and neuronal disorders. Stereotact. Funct. Neurosurg. 59, 92-99.
15. MARTUZA, R.L., MALICK, A., MARKERT, J.M., RUFFNER, K.I., and COEN, D.M. (1991). Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252, 854-856.
16. MINETA, T., RABKIN, S.D., YAZAKI, T., HUNTER, W.D., and MARTUZA, R.L. (1995). Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Med. 1, 938-943.
17. MINIGAWA, H., SAKUMA, S., MOHRI, S., and WATAMBE, T. (1988). Herpes simplex virus type 1 infection in mice with severe combined immunodeficiency (SCID). Arch. Virol. 103, 73-82.
18. MULLANEY, J., MOSS, H.W., and MCGEOCH, D.J. (1989). Gene UL2 of herpes simplex virus type 1 encodes a uracil-DNA glycosylase. J. Gen. Virol. 70, 449-454.
19. PAPIERZ, W., ALWASIAK, J., BIERNAT, W., and LIBERSKI, P.P. (1995). Neoplatic vascular tumors of the central nervous system. Folia Neuropath. 33, 215-220.
20. PYLES, R.B., and THOMPSON, R.L. (1994a). Evidence that the herpes simplex virus type 1 uracil DNA glycosylase is required for efficient viral replication and latency in the murine nervous system. J. Virol. 68, 4963-4972.
21. PYLES, R.B., and THOMPSON, R.L. (1994b). Mutations in accessory DNA replicating functions after the relative mutation frequency of herpes simplex virus type 1 strains with in cultured murine cells. J. Virol. 68, 4514-4524.
22. RANDAZZO, B.P., KESARI, S., GESSER, R.M., ALSOP, D., FORD, J.C., BROWN, S.M., MACLEAN, A., and FRASER, N.W. (1995). Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant. Virology 211, 94-101.
23. REED, L.J., and MUENCH, H. (1938). A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
24. ROBERTSON, L.M., MACLEAN, A.R., and BROWN, S.M. (1992). Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716. J. Gen. Virol. 73, 967-970.
25. ROIZMAN, B., and SEARS, A.E. (1990). Herpes simplex viruses and their replication. In Virology, 2nd ed. B.N. Fields et al., ed. (Raven Press, New York) pp. 1795-1841.
26. + γ34.5 deletion mutant 1716 is avirulent in SCID mice. J. Gen. Virol. 75, 2059-2063.
27. WEN, D.Y., HALL, W.A., CONRAD, J., GODAL, A., FLORENES, V.A., and FODSTAD, O. (1995). In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line. Neurosurgery 36, 1158-1163.
28. 1 34.5 deletion mutants in rodent models. J. Clin. Invest. 91, 2837-2843.